Literature DB >> 16645900

Comparison of HCMV IE and EF-1 promoters for the stable expression of beta-subunit of hexosaminidase in CHO cell lines.

Incilay Sinici1, Maryam Zarghooni, Michael B Tropak, Don J Mahuran, H Asuman Ozkara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16645900      PMCID： PMC2910080          DOI： 10.1007/s10528-006-9016-3

Source DB:  PubMed          Journal:  Biochem Genet        ISSN： 0006-2928            Impact factor:   1.890


× No keyword cloud information.
  16 in total

1.  Characterization of two Turkish beta-hexosaminidase mutations causing Tay-Sachs disease.

Authors:  Hatice Asuman Ozkara; Konrad Sandhoff
Journal:  Brain Dev       Date:  2003-04       Impact factor: 1.961

2.  Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis.

Authors:  S Zhang; R Bagshaw; W Hilson; Y Oho; A Hinek; J T Clarke; J W Callahan
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  Biochemical consequences of mutations causing the GM2 gangliosidoses.

Authors:  D J Mahuran
Journal:  Biochim Biophys Acta       Date:  1999-10-08

6.  The human elongation factor 1 alpha (EF-1 alpha) first intron highly enhances expression of foreign genes from the murine cytomegalovirus promoter.

Authors:  Seon-Young Kim; Jae-Ho Lee; Hyun-Seock Shin; Hye-Ja Kang; Yeon-Soo Kim
Journal:  J Biotechnol       Date:  2002-02-14       Impact factor: 3.307

7.  Assessing the severity of the small inframe deletion mutation in the alpha-subunit of beta-hexosaminidase A found in the Turkish population by reproducing it in the more stable beta-subunit.

Authors:  I Sinici; M B Tropak; D J Mahuran; H A Ozkara
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

8.  Comparison between cytomegalovirus promoter and elongation factor-1 alpha promoter-driven constructs in the establishment of cell lines expressing hepatitis C virus core protein.

Authors:  K Tokushige; D Moradpour; T Wakita; M Geissler; N Hayashi; J R Wands
Journal:  J Virol Methods       Date:  1997-02       Impact factor: 2.014

9.  Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines.

Authors:  Sangmi Chung; Therese Andersson; Kai-C Sonntag; Lars Björklund; Ole Isacson; Kwang-Soo Kim
Journal:  Stem Cells       Date:  2002       Impact factor: 6.277

10.  Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus.

Authors:  Christian Teschendorf; Kenneth H Warrington; Dietmar W Siemann; Nicholas Muzyczka
Journal:  Anticancer Res       Date:  2002 Nov-Dec       Impact factor: 2.480
View more
  2 in total

1.  Positron emission tomography reporter gene strategy for use in the central nervous system.

Authors:  Tom Haywood; Corinne Beinat; Gayatri Gowrishankar; Chirag B Patel; Israt S Alam; Surya Murty; Sanjiv Sam Gambhir
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-23       Impact factor: 11.205

2.  Development of Minicircle Vectors Encoding COL7A1 Gene with Human Promoters for Non-Viral Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa.

Authors:  Xianqing Wang; Fatma Alshehri; Darío Manzanares; Yinghao Li; Zhonglei He; Bei Qiu; Ming Zeng; Sigen A; Irene Lara-Sáez; Wenxin Wang
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.